The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010
Open accessAbstract
IMPORTANCE: Type 1 diabetes has historically been associated with a significant reduction in life expectancy. Major advances in treatment of type 1 diabetes have occurred in the past 3 decades. Contemporary estimates of the effect of type 1 diabetes on life expectancy are needed. OBJECTIVE: To examine current life expectancy in people with and without type 1 diabetes in Scotland. We also examined whether any loss of life expectancy in patients with type 1 diabetes is confined to those who develop kidney disease. DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort of all individuals alive in Scotland with type 1 diabetes who were aged 20 years or older from 2008 through 2010 and were in a nationwide register (n=24,691 contributing 67,712 person-years and 1043 deaths). MAIN OUTCOMES AND MEASURES: Differences in life expectancy between those with and those without type 1 diabetes and the percentage of the difference due to various causes. RESULTS: Life expectancy at an attained age of 20 years was an additional 46.2 years among men with type 1 diabetes and 57.3 years among men without it, an estimated loss in life expectancy with diabetes of 11.1 years (95% CI, 10.1-12.1). Life expectancy from age 20 years was an additional 48.1 years among women with type 1 diabetes and 61.0 years among women without it, an estimated loss with diabetes of 12.9 years (95% CI, 11.7-14.1). Even among those with type 1 diabetes with an estimated glomerular filtration rate of 90 mL/min/1.73 m2 or higher, life expectancy was reduced (49.0 years in men, 53.1 years in women) giving an estimated loss from age 20 years of 8.3 years (95% CI, 6.5-10.1) for men and 7.9 years (95% CI, 5.5-10.3) for women. Overall, the largest percentage of the estimated loss in life expectancy was related to ischemic heart disease (36% in men, 31% in women) but death from diabetic coma or ketoacidosis was associated with the largest percentage of the estimated loss occurring before age 50 years (29.4% in men, 21.7% in women). CONCLUSIONS AND RELEVANCE: Estimated life expectancy for patients with type 1 diabetes in Scotland based on data from 2008 through 2010 indicated an estimated loss of life expectancy at age 20 years of approximately 11 years for men and 13 years for women compared with the general population without type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cardiovascular disease remains the major cause of premature morbidity and mortality, with data119,120 suggesting an 8–13-year shorter life expectancy for people with type 1 diabetes than for healthy individuals.”
From Type 1 diabetes (2018) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due in part to the success of modern diabetes management, people with type 1 diabetes are living longer, and the population of these people over 65 years of age is growing (121-123).”
From 13. Older Adults: Standards of Care in Diabetes—2024 (2024) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due in part to the success of modern diabetes management, people with type 1 diabetes are living longer, and the population of these people over 65 years of age is growing (136-138).”
From 13. Older Adults: Standards of Care in Diabetes—2025 (2025) · cites this paper as [136]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In Scotland, mortality rates in 2008–2010 increased from 31.9 and 24.2 per 1,000 person-years in men and women, respectively, with T1DM who were aged 60–64 years to 142.7 in men and 171.3 in women aged ≥80 years39.”
From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In Scotland, reductions in life expectancy for people with T1DM aged 60–64 years were 5.6 years and 7.1 years for men and women, respectively39.”
From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [39]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due in part to the success of modern diabetes management, people with type 1 diabetes are living longer, and the population of people over 65 years with type 1 diabetes is growing (154–156).”
From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [154]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854
Introduction to Stochastic Processes in Biostatistics
Bartlett, M. S., & Chiang, C. L. (1969) · Revue de l Institut International de Statistique / Review of the International Statistical Institute · doi:10.2307/1402301 · Cited by 684
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638
Measuring and explaining the change in life expectancies
Arriaga, E. E. (1984) · Demography · doi:10.2307/2061029 · Cited by 630
Type 1 Diabetes Mellitus and Cardiovascular Disease
de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 516
de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1720 · Cited by 444
High Risk of Cardiovascular Disease in Patients With Type 1 Diabetes in the U.K.
Soedamah‐Muthu, S. S., Fuller, J., Mulnier, H. E., Raleigh, V. S., Lawrenson, R. A., & Colhoun, H. M. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1433 · Cited by 395
Self-citationLivingstone, S. J., Looker, H. C., Hothersall, E. J., Wild, S. H., Lindsay, R. S., Chalmers, J., Cleland, S. J., Leese, G., McKnight, J. A., Morris, A. D., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001321 · Cited by 356
Self-citationOrchard, T. J., Secrest, A. M., Miller, R. G., & Costacou, T. (2010) · Diabetologia · doi:10.1007/s00125-010-1860-3 · Cited by 317
Cited by
Sorted by citations
Items 301–400 of 622
SGLT2 inhibitors and renal complications in type 1 diabetes
Petrie, J. R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30311-9 · Cited by 11
Self-citationLi, C., Wei, B., & Zhao, J. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00877-3 · Cited by 11
Ritsinger, V., Hero, C., Svensson, A., Saleh, N., Lagerqvist, B., Eeg‐Olofsson, K., & Norhammar, A. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487316687860 · Cited by 11
Fagherazzi, G. (2021) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2021.100004 · Cited by 10
Generation of Chimeric Antigen Receptors against Tetraspanin 7
Pieper, T., Roth, K. D. R., Glaser, V., Riët, T., Buitrago‐Molina, L. E., Hagedorn, M., Lieber, M., Hust, M., Noyan, F., Jaeckel, E., et al. (2023) · Cells · doi:10.3390/cells12111453 · Cited by 12
STOUGAARD, E. B., Amadid, H., Søndergaard, E., Carstensen, B., Jørgensen, M. E., Nørgaard, K., Rossing, P. R., Persson, F., & Vistisen, D. (2023) · Diabetes Care · doi:10.2337/dc23-0475 · Cited by 10
Corrales, P. J. P., Marcos, J. S., Gallardo, G. L., Moreno-Fernández, J., Antolín, S. H., López, I. Q., Zaballos, F. D. V., López, J. G., & Martínez, J. J. A. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.11.003 · Cited by 10
SGLT inhibitors for people with type 1 diabetes
Llano, A., McKay, G., & Fisher, M. (2019) · Practical Diabetes · doi:10.1002/pdi.2222 · Cited by 10
Ramírez‐Mendoza, F., González, J. E., Gasca, E., Camacho, M., Cruz, M. V., Caraveo, D., Velázquez, A., Cruz, Z., Segoviano, M., Romano, M., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12921 · Cited by 10
Gao, M. H., Giamouridis, D., Lai, N. C., Guo, T., Xia, B., Kim, Y. C., Huu, V. A. N., Skowronska‐Krawczyk, D., Lantier, L., Bhargava, R., et al. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.12.002 · Cited by 10
Couper, J., Jones, T. W., Chee, M., Barrett, H. L., Bergman, P. B., Cameron, F. J., Craig, M. E., Colman, P. G., Davis, E. E., Donaghue, K. C., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa727 · Cited by 10
Seetharaman, S., & Cengiz, E. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241309896 · Cited by 9
Olatunde, A., Saravanan, K., Ogunro, O. B., Obidola, M. S., Jakwa, A., Lawal, A. T., Shittu, A. A., Tijjani, H., Umar, H., Ozsahin, D. U., et al. (2025) · Discover Medicine · doi:10.1007/s44337-025-00333-6 · Cited by 9
Shi, F., Zhao, Q., Yang, Y., Liu, L., Zhang, X., Kim, H. J., Wang, Y., & Pu, J. (2025) · BMC Medicine · doi:10.1186/s12916-025-04361-y · Cited by 9
Espes, D., Lau, J., & Carlsson, P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0080 · Cited by 10
Cardiovascular health in emerging adults with type 1 diabetes
McCarthy, M. M., Yan, J., Jared, M. C., You, E., Ilkowitz, J. T., GALLAGHER, M. P., & Dickson, V. V. (2021) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvab062 · Cited by 9
Höhn, A., McGurnaghan, S. J., Caparrotta, T. M., Jeyam, A., O’Reilly, J. E., Blackbourn, L. A. K., Hatam, S., Dudel, C., Seaman, R., Mellor, J., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271110 · Cited by 9
Self-citationLong-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction
Kerola, A. M., Semb, A. G., Juonala, M., Palomäki, A., Rautava, P. T., & Kytö, V. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01608-3 · Cited by 9
Tynjälä, A., Harjutsalo, V., Sigfrids, F. J., Groop, P., Gordin, D., & the FinnDiane Study Group (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01770-2 · Cited by 9
Progression and regression of kidney disease in type 1 diabetes
Sigfrids, F. J., & Groop, P. (2023) · Frontiers in Nephrology · doi:10.3389/fneph.2023.1282818 · Cited by 9
Collier, A., Connelly, P. J., Hair, M. D., Cameron, L., Ghosh, S. K., & Waugh, N. R. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13334 · Cited by 9
Insulin: still a miracle after all these years
Barbetti, F., & Taylor, S. I. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130310 · Cited by 9
Basu, A., Alman, A. C., & Snell‐Bergeon, J. K. (2022) · Journal of Diabetes Research · doi:10.1155/2022/4747573 · Cited by 9
Mayerhöfer, T., Klein, S., Wernly, B., Flaatten, H. K., Guidet, B., de Lange, D. W., Fjølner, J., Leaver, S. K., Beil, M., Sviri, S., et al. (2023) · Infection · doi:10.1007/s15010-023-02001-2 · Cited by 9
Recent advances in type 1 diabetes
Kyi, M., Wentworth, J. M., Nankervis, A. J., Fourlanos, S., & Colman, P. G. (2015) · The Medical Journal of Australia · doi:10.5694/mja14.01691 · Cited by 9
Singh, K. N., Sandler, S., & Espes, D. (2017) · Journal of Diabetes Research · doi:10.1155/2017/6192896 · Cited by 9
Rohani, H., Sadeghi, E., Eslami, A. A., Raei, M., & Jafari‐Koshki, T. (2018) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_394_16 · Cited by 9
Zhang, X., Xu, D., Xu, P., Yang, S., Zhang, Q., Wu, Y., & Yuan, F. (2021) · Endocrine Connections · doi:10.1530/ec-21-0146 · Cited by 9
Watso, J. C., Robinson, A. T., Singar, S., Cuba, J. N., & Koutnik, A. P. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00694.2023 · Cited by 8
Molecular and Inflammatory Etiologies of β-Cell Dysfunction in Type 1 Diabetes
Rostron, C. R., & Evans‐Molina, C. (2025) · Physiology · doi:10.1152/physiol.00008.2025 · Cited by 9
Masouri, M. M., Ebrahimi, R., & Noori, S. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70060 · Cited by 8
Lei, M., Zhou, Y., Ni, Y., Lin, Z., Lin, Q., Ling, P., Yang, D., Xu, W., Deng, H., & Yan, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70355 · Cited by 8
Ren, X., Ninglin, K., Yu, X., Li, X., Tang, Y., & Wu, J. (2023) · Medicine · doi:10.1097/md.0000000000032911 · Cited by 8
Cantley, J., Eizirik, D. L., Latres, E., Dayan, C. M., & _, _. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0082 · Cited by 8
Holman, N., Young, B., Gregg, E. W., Wareham, N. J., Sharp, S. J., Khunti, K. K., Sattar, N. A., & Valabhji, J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15783 · Cited by 8
Self-citationTaylor, G., Moser, O., Smith, K., Shaw, A., TANG, J. C. Y., Fraser, W. D., Eckstein, M. L., Aziz, F., Stevenson, E., Shaw, J., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001779 · Cited by 8
Llauradó, G., Amigó, N., Fuertes-Martín, R., Romero, A., Cano, A., Albert, L., Giménez‐Palop, O., Berlanga, E., Fernández‐Veledo, S., Correig, X., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0331 · Cited by 8
Lens-Pechakova, L. S. (2015) · Rejuvenation Research · doi:10.1089/rej.2015.1690 · Cited by 8
Komorita, Y., Minami, M., Maeda, Y., Yoshioka, R., Ohkuma, T., & Kitazono, T. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002099 · Cited by 8
Basu, A., Jenkins, A. J., Stoner, J. A., Zhang, Y., Klein, R. L., Lopes-Virella, M. F., Garvey, W. T., Schade, D. S., Wood, J., Alaupovic, P., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p080143 · Cited by 8
Chuang, S.-T., Alcazar, O., Watts, B. M., Abdulreda, M. H., & Buchwald, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1484425 · Cited by 7
Guo, X., Zhang, Z., Li, C., Li, X., Cao, Y., Wang, Y., Li, J., Wang, Y., Wang, K., Liu, Y., et al. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100354 · Cited by 7
Gjorup, A. L. T., Snoek, F. J., & van Duinkerken, E. (2021) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2021.727029 · Cited by 9
Estimating the cost of type 1 diabetes in Ireland
Sharma, S., Gillespie, P., Hobbins, A. P., & Dinneen, S. F. (2021) · Diabetic Medicine · doi:10.1111/dme.14779 · Cited by 7
Are Clinicians Aggressive Enough in Treating Diabetes-Related Hyperlipidemia in Youth?
Jackson, S., Creo, A. L., & Kumar, S. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01020-y · Cited by 8
Alshaikh, L., & Doherty, A. M. (2023) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2023.100325 · Cited by 7
Methylglyoxal-Derived Nucleoside Adducts Drive Vascular Dysfunction in a RAGE-Dependent Manner
Lai, S. W. T., Bhattacharya, S., Gonzalez, E. D. J. L., & Shuck, S. C. (2024) · Antioxidants · doi:10.3390/antiox13010085 · Cited by 7
Al‐Ozairi, E., Irshad, M., Al-Ozairi, A., Alkandari, J., Taghadom, E., Varghese, A. L., Megahed, A., Abdullah, A., Murad, S., & Gray, S. R. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103046 · Cited by 7
Lakshmi, K., Deeba, K., Harave, V., & Bharti, S. (2024) · International Conference on Knowledge Engineering and Communication Systems (ICKECS) · doi:10.1109/ickecs61492.2024.10616598 · Cited by 7
Madhu, S. V., Shukla, P. K., Kaur, T., & Dhaliwal, R. S. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111868 · Cited by 7
Winje, E., Lake, I., & Dankel, S. N. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1404842 · Cited by 7
Microvascular diabetes complications in a specialist young adult diabetes service
Melvin, A., Redahan, L., Hatunic, M., & McQuaid, S. (2018) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-018-1827-9 · Cited by 7
Ahola, A. J., Harjutsalo, V., Thomas, M. C., Forsblom, C. M., & Groop, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-81180-0 · Cited by 7
Prevalence of Type 2 and Type 1 Diabetes in Psoriatic Arthritis
Ciaffi, J., Mele, G., Mancarella, L., Brusi, V., Lisi, L., Cordella, J. F., Lubrano, E., D’Angelo, S., Melicòni, R., & Ursini, F. (2021) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001706 · Cited by 7
Feasibility of large experimental animal models in testing novel therapeutic strategies for diabetes
Nagaya, M., Hasegawa, K., Uchikura, A., Nakano, K., Watanabe, M., Umeyama, K., Matsunari, H., Osafune, K., Kobayashi, E., Nakauchi, H., et al. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i4.306 · Cited by 7
Alcazar, O., Ogihara, M., Ren, G., Buchwald, P., & Abdulreda, M. H. (2022) · Biomolecules · doi:10.3390/biom12101444 · Cited by 7
Berger, B., Sethe, D., Hilgard, D., Martin, D. D., & Heusser, P. (2017) · Complementary Medicine Research · doi:10.1159/000479532 · Cited by 7
Heller, T., Kloos, C., Lehmann, T., Schiel, R., Lorkowski, S., Wolf, G., Müller, U., & Muller, N. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-113452 · Cited by 7
New era of therapy for endocrine autoimmune disorders
Oftedal, B. E., & Wolff, A. S. B. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12961 · Cited by 7
What do we know about biomarkers in diabetic kidney disease?
Kwiendacz, H., Nabrdalik, K., Stompór, T. P., & Gumprecht, J. (2020) · Endokrynologia Polska · doi:10.5603/ep.a2020.0077 · Cited by 7
The 3p21.31 genetic locus promotes progression to type 1 diabetes through the CCR2/CCL2 pathway
Tran, P. M. H., Purohit, S. B., Kim, E., Satter, K. B., Hopkins, D., Waugh, K., Dong, F., Önengüt-Gümüşcü, S., Rich, S. S., Rewers, M., et al. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100127 · Cited by 7
The epidemiology of type 1 diabetes: Helping to fit the puzzle pieces
Forga, L. (2015) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2015.02.011 · Cited by 7
The Effectiveness of Cognitive-Focused Interventions for Adults With Diabetes: A Systematic Review
Kim, B., & Hu, J. (2024) · Western Journal of Nursing Research · doi:10.1177/01939459231221939 · Cited by 6
Zou, M., & Yang, J. (2024) · Pharmaceuticals · doi:10.3390/ph17060766 · Cited by 6
Sarkar, S., Zheng, X., Clair, G., Kwon, Y. M., You, Y., Swensen, A., Webb‐Robertson, B., Nakayasu, E. S., Qian, W.-J., & Metz, T. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.07.009 · Cited by 6
Pollé, O. G., Ruys, S. P. D., Lemmer, J., Hubinon, C., Martin, M., Herinckx, G., Gatto, L., Vertommen, D., & Lysy, P. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-71717-4 · Cited by 6
Saeed, Z. I., Aktürk, H. K., Aleppo, G., Kruger, D. F., Levy, C. J., Mader, J. K., Sherr, J. L., & Shah, V. N. (2024) · Clinical Diabetes · doi:10.2337/cd24-0067 · Cited by 7
Genetics of C-Peptide and Age at Diagnosis in Type 1 Diabetes
Roshandel, D., Spiliopoulou, A., McGurnaghan, S. J., Iakovliev, A., Lipschutz, D., Hayward, C., Bull, S. B., Klein, B. E. K., Lee, K. E., Kinney, G. L., et al. (2024) · Diabetes · doi:10.2337/db24-0340 · Cited by 6
Self-citationMakvandi, K., Eliasson, B., Carlsen, H. K., & Baid‐Agrawal, S. (2024) · Diabetes Care · doi:10.2337/dc24-0908 · Cited by 8
Diabetes mellitus Typ 1 – Update
Kordonouri, O., & Kerner, W. (2021) · Der Internist · doi:10.1007/s00108-021-01009-w · Cited by 6
Padovano, M., Scopetti, M., Manetti, F., Morena, D., Radaelli, D., D’Errico, S., Fazio, N. D., Frati, P., & Fineschi, V. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i8.577 · Cited by 6
Maguolo, A., Rioda, M., Zusi, C., Emiliani, F., Olivieri, F., Piona, C. A., Marigliano, M., Orsi, S., Morandi, A., & Maffeis, C. (2022) · Hormone Research in Paediatrics · doi:10.1159/000527520 · Cited by 6
The potential of colchicine for lowering the risk of cardiovascular events in type 1 diabetes
Johansen, N. J., & Knop, F. K. (2023) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvad005 · Cited by 7
Phytoconstituents Based Nanomedicines for the Management of Diabetes: A Review
Jadhav, S. B., & Yadav, A. (2023) · Pharmaceutical Nanotechnology · doi:10.2174/2211738511666230118095936 · Cited by 6
Haas, J., Franko, M. A., Olinder, A. L., Nyström, T., & Persson, M. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110899 · Cited by 8
Peptide secretion triggers diabetes
Wei, J., & Yewdell, J. W. (2018) · Nature · doi:10.1038/d41586-018-05710-z · Cited by 6
Ryckeghem, L. V., Franssen, W. M. A., Verbaanderd, E., Indesteege, J., Vriendt, F. D., Verwerft, J., Dendale, P., Bito, V., & Hansen, D. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.01.010 · Cited by 6
Proteoma urinario en la enfermedad renal diabética. Estado del arte
Rico-Fontalvo, J. E., Daza-Arnedo, R., Raad-Sarabia, M., Pájaro-Galvis, N., Bello-Espinosa, A., Uparella-Gulfo, I., Calvo, C. P., Pomares-Lara, A., Almeida, Z. M., Serpa, O. V. V., et al. (2021) · Revista Colombiana de Nefrología · doi:10.22265/acnef.8.3.546 · Cited by 6
Epidemiology of Type 1 Diabetes
Stene, L. C., & Tuomilehto, J. O. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch4 · Cited by 6
ComputAgeBench: Epigenetic Aging Clocks BenchmarkPreprint
Kriukov, D. V., Efimov, E., Kuzmina, E., Dudkovskaia, A., Khrameeva, E. E., & Dylov, D. V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.06.597715 · Cited by 6
Therapeutic Inertia Quantification in Diabetes Care: A Narrative Review and Synthesis
Zoukh, I. M., Dabbous, Z., Owusu, Y., & Awaisu, A. (2025) · Clinical Therapeutics · doi:10.1016/j.clinthera.2025.02.003 · Cited by 5
Kahkoska, A. R., Neumiller, J. J., Alexopoulos, A., Christiaens, A., Cukierman‐Yaffe, T., Ehrhardt, N. M., Huang, E. S., Idrees, T., Laffel, L. M., Lee, S. J., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-10053-3 · Cited by 5
Paliares, I. C., Dualib, P. M., Aroucha, P. M. T., Torres, L. S. N., de Sá, J. R., & Dib, S. A. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112386 · Cited by 6
Diabetic Foot Ulcer: An Easy and Comprehensive Approach
Shaikh, I., Masood, N., & Shaikh, J. H. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92585 · Cited by 5
Perry, L., Dunbabin, J. S., Xu, X., LOWE, J. M., Acharya, S., James, S., & Steinbeck, K. S. (2020) · Australian Health Review · doi:10.1071/ah19117 · Cited by 6
Camoin, M., Velho, G., Saulnier, P., Potier, L., Abouleka, Y., Carpentier, C., Dubois, S. G., Larroumet, A., Rigalleau, V., Gand, E., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01487-8 · Cited by 6
Lee, C.-H., Tsai, C.-I., Su, Y., Lin, S., Lee, I., & Li, T. (2022) · Medicine · doi:10.1097/md.0000000000032342 · Cited by 5
Zhao, J., Li, W., Chen, L., Li, M., & Deng, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1407329 · Cited by 5
Interventions Targeting Insulin Resistance in Patients with Type 1 Diabetes: A Narrative Review
Herascu, A., Avram, V. F., Gaiţă, L., Sima, A. C., Reurean‐Pintilei, D., & Timar, B. (2024) · Medicina · doi:10.3390/medicina60122067 · Cited by 5
Paes, V. M., Charalampopoulos, D., Khanolkar, A. R., Taylor-Robinson, D. C., Viner, R., Edge, J., Stephenson, T. J., & Amin, R. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0146-8 · Cited by 5
Highs and lows of diabetic care: lessons from a national audit
Warner, J. (2017) · Archives of Disease in Childhood · doi:10.1136/archdischild-2016-311373 · Cited by 5
Xenotransplantation of the endocrine pancreas
Smood, B. F., Bottino, R., & Cooper, D. K. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814831-0.00031-2 · Cited by 5
JENDLE, J. H., Ampudia‐Blasco, F. J., Füchtenbusch, M., & Pozzilli, P. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.1.12 · Cited by 5
Phowira, J., Ahmed, F. W., Bakhashab, S., & Weaver, J. U. (2022) · Biomedicines · doi:10.3390/biomedicines10092136 · Cited by 5
Prevention of Type 1 Diabetes: Current Perspective
Pande, A. K., Dutta, D., & Singla, R. (2023) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_78_23 · Cited by 6
Bakhashab, S., O’Neill, J., Barber, R., Arden, C., & Weaver, J. U. (2024) · Biomedicines · doi:10.3390/biomedicines12010171 · Cited by 5
The challenges of type 1 diabetes in older people
Kilvert, A., & Fox, C. (2015) · Practical Diabetes · doi:10.1002/pdi.1952 · Cited by 5
Novel therapies for T1D on the horizon
Nasr, M. B., & Fiorina, P. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.019 · Cited by 6
Antikainen, A. A., Mutter, S., Harjutsalo, V., Thorn, L. M., Groop, P., Sandholm, N., & the FinnDiane Study Group (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02512-8 · Cited by 4
Fragozo-Ramos, M. C., Schenker, G., Hepprich, M., Gallo‐Villegas, J., Züger, T., & Garcia‐Tirado, J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0335060 · Cited by 4
Metadata
- Authors
- Livingstone, S. J., Levin, D., Looker, H. C., Lindsay, R. S., Wild, S. H., Joss, N., Leese, G., Leslie, P., McCrimmon, R. J., Metcalfe, W., McKnight, J. A., Morris, A. D., Pearson, D. W. M., Petrie, J. R., Philip, S., Sattar, N. A., Traynor, J. P., & Colhoun, H. M.
- Affiliations
- University of Dundee (GB)
- University of Glasgow (GB)
- University of Edinburgh (GB)
- Raigmore Hospital (GB)
- Borders General Hospital (GB)
- Scottish Renal Registry, Paisley, Scotland
- Western General Hospital (GB)
- NHS Grampian (GB)
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2015-01-06
- Volume
- 313
- Issue
- 1
- Pages
- 37
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC4426486
- OpenAlex
- W1965748339
- Cited by
- 621
- References
- 19
- Citations by year
- 2026: 39 · 2025: 46 · 2024: 49 · 2023: 55 · 2022: 66 · 2021: 64 · 2020: 59 · 2019: 62 · 2018: 51 · 2017: 39 · 2016: 48 · 2015: 42
- FWCI
- 52.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Funders
- Wellcome Trust (086113)
- Diabetes UK (10/0004010)
- Medical Research Council (MR/M501633/1, MR/K007017/1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 1 diabetes, life expectancy, life expectancy loss, kidney disease, estimated glomerular filtration rate, ischemic heart disease, diabetic ketoacidosis, diabetic coma, sex differences, causes of death, Scotland, life expectancy at age 65
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cause of Death, Diabetes Mellitus, Type 1, Diabetic Coma, Female, Humans, Life Expectancy, Male, Middle Aged, Prospective Studies, Scotland, Sex Factors, Myocardial Ischemia, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
